DiscoverCoronavirus (COVID-19) Q&A;Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Update: 2024-02-06
Share

Description

Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.

Related Content:

Comments 
In Channel
Global COVID-19 Update

Global COVID-19 Update

2022-10-0519:43

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents